Hospital
Healthmark of Walton INC
Healthmark of Walton INC was paid $1.30M by Medicaid between Jan 2018 and Dec 2022, across 72 billing codes. Its largest line is 99282, Emergency department visit for the evaluation and management, low to moderate severity — 35% of everything it billed.
33Billing provider infoHEALTHMARK OF WALTON INC
DEFUNIAK SPRINGS, FL 32435
DEFUNIAK SPRINGS, FL 32435
33aNPI1710984299assigned 06/30/2005
33bProvider typeRural Acute Care Hospital
28Total paid$1.30M
24GClaims66,105
24DCodes billed72
24AFirst – last monthJan 2018 – Dec 2022
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 4,544 | $49K | |
| 2019 | 18,836 | $350K | |
| 2020 | 19,156 | $293K | |
| 2021 | 19,056 | $420K | |
| 2022 | 4,513 | $187K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 35% | 13,756 | 8,312 | $461K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 11% | 1,932 | 1,648 | $137K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 10% | 3,248 | 2,874 | $133K |
| 36415 | Collection of venous blood by venipuncture | 8.3% | 5,684 | 4,477 | $108K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 5.0% | 1,453 | 1,293 | $66K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 4.4% | 1,613 | 1,310 | $57K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 3.6% | 1,367 | 1,142 | $46K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 2.0% | 406 | 333 | $27K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.7% | 648 | 526 | $23K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 1.7% | 528 | 414 | $22K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.4% | 484 | 463 | $18K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 1.4% | 251 | 225 | $18K |
60 more codes
| C1751 | Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) | 1.3% | 1,870 | $17K |
| J1094 | Injection, dexamethasone acetate, 1 mg | 1.3% | 219 | $16K |
| 80053 | Comprehensive metabolic panel | 1.1% | 4,592 | $15K |
| 71046 | Radiologic examination, chest; 2 views | 1.1% | 702 | $14K |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 125 | $11K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,563 | $10K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 397 | $9K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 4,297 | $8K |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 109 | $7K |
| 71045 | Radiologic examination, chest; single view | <1% | 869 | $6K |
| J7510 | Prednisolone oral, per 5 mg | <1% | 94 | $5K |
| A4556 | Electrodes, (e.g., apnea monitor), per pair | <1% | 436 | $5K |
| A6454 | Self-adherent bandage, elastic, non-knitted/non-woven, width greater than or equal to three inches and less than five inches, per yard | <1% | 74 | $5K |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 135 | $4K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 1,245 | $4K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 828 | $4K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 202 | $4K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 78 | $4K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,237 | $4K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 1,189 | $3K |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 83 | $3K |
| 81003 | <1% | 593 | $3K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 394 | $3K |
| 81001 | <1% | 1,317 | $3K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,737 | $2K |
| 81000 | <1% | 569 | $2K | |
| 83735 | <1% | 1,306 | $2K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 54 | $2K |
| 87088 | <1% | 832 | $1K | |
| 80061 | Lipid panel | <1% | 934 | $1K |
| 81025 | <1% | 516 | $1K | |
| 83690 | <1% | 516 | $839.09 | |
| 82150 | <1% | 418 | $816.36 | |
| 84479 | <1% | 649 | $784.74 | |
| 84484 | <1% | 414 | $729.62 | |
| 84436 | <1% | 463 | $689.65 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 46 | $587.67 |
| 84439 | <1% | 278 | $551.43 | |
| 73630 | <1% | 26 | $546.01 | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 360 | $520.93 |
| 83970 | <1% | 48 | $495.05 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 417 | $485.25 |
| 72110 | <1% | 14 | $402.50 | |
| 82550 | <1% | 287 | $397.11 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 308 | $396.73 |
| 84681 | <1% | 168 | $318.31 | |
| 86038 | <1% | 54 | $301.69 | |
| 94664 | <1% | 75 | $234.82 | |
| 85651 | <1% | 100 | $230.11 | |
| 83880 | <1% | 50 | $67.12 | |
| 82607 | <1% | 69 | $66.17 | |
| 82728 | <1% | 147 | $14.91 | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 33 | $7.26 |
| 86430 | <1% | 14 | $5.22 | |
| 83550 | 0% | 51 | $0.00 | |
| 82746 | 0% | 34 | $0.00 | |
| 83655 | 0% | 12 | $0.00 | |
| 83540 | 0% | 49 | $0.00 | |
| 87186 | 0% | 18 | $0.00 | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 0% | 21 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHOLLEY, LISA (COO)
| Provider | Location | Paid |
|---|---|---|
| Healthmark of Walton Rural Health Clinic INC | Defuniak Springs, FL | $142K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.